Ardent Health, Inc.
ARDT· NYSE
Filed Aug 14, 2024 · 10-Q · 45 days after period end · 0001628280-24-037278
| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Revenue | $1.47B | $1.37B |
| Net Income | $42.77M | $33.08M |
| EPS Diluted | $0.34 | $0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ardent Health, Inc. · CIK 1756655 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end